RJA
AMRS

Raymond James & Associates’s Amyris Inc. AMRS Stock Holding History

Raymond James & Associates’s Portfolio AMRS Stock Details AMRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,219
Closed -$36 – 4098
2023
Q4 		$36 Sell
14,219
-608
-4% -$2 ﹤0.01% 3823
2023
Q3 		$890 Sell
14,827
-19,236
-56% -$14.3K ﹤0.01% 3786
2023
Q2 		$35.1K Hold
34,063
– – ﹤0.01% 3732
2023
Q1 		$46.3K Sell
34,063
-655
-2% -$936 ﹤0.01% 3736
2022
Q4 		$53.1K Sell
34,718
-5,645
-14% -$12.6K ﹤0.01% 3711
2022
Q3 		$118K Sell
40,363
-19,792
-33% -$54K ﹤0.01% 3579
2022
Q2 		$111K Buy
60,155
+20,616
+52% +$60.7K ﹤0.01% 3663
2022
Q1 		$172K Buy
39,539
+15,535
+65% +$69.7K ﹤0.01% 3713
2021
Q4 		$130K Sell
24,004
-3,336
-12% -$31.1K ﹤0.01% 3814
2021
Q3 		$375K Buy
+27,340
New +$391K ﹤0.01% 3258

Other funds holding AMRS

FC
FCA Corp Houston, Texas $354M AUM 17.74% 1-Year Est. Return
CAM
Cozad Asset Management Champaign, Illinois $1.27B AUM 31.6% 1-Year Est. Return
TSMHT
Thurston Springer Miller Herd & Titak Indianapolis, Indiana $275M AUM 30.64% 1-Year Est. Return

Raymond James & Associates's AMRS Position: Q1 2024 in Review

Raymond James & Associates sold out of Amyris Inc. (AMRS) in Q1 2024, closing a stake of 14,219 shares — an estimated $36 sold.

Raymond James & Associates first reported a position in AMRS in Q3 2021 and held it in 10 quarters. The position peaked at $375K in Q3 2021. 3 funds tracked by Wall St. Rank hold AMRS as of Q1 2024.

  • Raymond James & Associates reported no remaining Amyris Inc. position as of Q1 2024 after selling out during the quarter.
  • Raymond James & Associates sold 14,219 Amyris Inc. shares in Q1 2024, an estimated $36.
  • Raymond James & Associates first reported a position in Amyris Inc. in Q3 2021 and held it in 10 quarters.
  • Raymond James & Associates's Amyris Inc. position peaked at $375K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Amyris Inc. as of Q1 2024.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.